Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial

David M. Charytan(NYU Langone Health), Jasmine Rollins, Renu Regunathan-Shenk(George Washington University), Daniel E. Weiner(Tufts Medical Center), Dominic S. Raj(George Washington University), Alan S. Kliger(Yale University), Jesse Y. Hsu(University of Pennsylvania), Rajnish Mehrotra(University of Washington), Hicham Skali(Dana-Farber/Harvard Cancer Center), Brigitte Brannon, Lori Linke, Charles D. Ellis(University of Pennsylvania), A. Henry Clagett, Paul Seok, T. Alp İkizler(Vanderbilt University), Sarah F. Andrews(National Institutes of Health), Laura M. Dember(Boston University), J. Richard Landis(University of Pennsylvania), Cindy Booker, Adriana M. Hung(Nashville Oncology Associates), Michelle Dumadag, Tayyaba Nizam, Caroline Smith(Western Sydney University), Jonathan Himmelfarb(University of Washington), Kerri L. Cavanaugh(PragmatIC (United Kingdom)), Lisa Anderson(St George's, University of London), E. Clare Robinson(Beth Israel Deaconess Medical Center), Amanda H. Anderson(University of Pennsylvania), Ezra Aurien-Blajeni, Ali Ramezani(George Washington University), Mark E. Williams(Brigham and Women's Hospital), Sookyung Rim(National Institute of Diabetes and Digestive and Kidney Diseases), Paul L. Kimmel(Anna Needs Neuroblastoma Answers), M Cinelli, Christina Franco, Shailendra Sharma(George Washington University), Maria R. Wing(UC San Diego Health System), L. Manahan(Vanderbilt University Medical Center), Marcelo F. DiCarli(Harper University Hospital)

Kidney International

November 23, 2018

Cited by 104

Related Papers

|Data Archiving and Networked Services (DANS)|2002|11.7k

|New England Journal of Medicine|2019|6k

|PLoS ONE|2012|1.8k

|American Journal of Kidney Diseases|2015|1.3k

|JAMA|2019|1.2k